Patent details

Basic Information

Publication number:

EP2373294

PCT Application Number:

PCT/US/2009/067538

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097683155

PCT Publication Number:

WO/2010/090677

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CLOSTRIDIAL TOXIN PHARMACEUTICAL COMPOSITIONS

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES COMPRENANT TOXINE DE CLOSTRIDIUM

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT CLOSTRIDIA-TOXIN

SPC Number:

Dates

Filing date:

10/12/2009

Grant date:

20/04/2016

EP Publication Date:

20/04/2016

PCT Publication Date:

12/08/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/10/2011

EP B1 Publication Date:

20/04/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/12/2016

Expiration date:

10/12/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/12/2009

 

 

Name:

ALLERGAN INC.

Address:

2525 Dupont Drive, T2-7h, Irvine, CA 92612, United States (US)

Inventor

1

Name:

KUMAR Harish P.M.

Address:

United States (US)

2

Name:

TRAN Huong T.

Address:

United States (US)

3

Name:

DASARI Gopal

Address:

United States (US)

4

Name:

PRASEUTH Alex

Address:

United States (US)

5

Name:

XIE Jack Z.

Address:

United States (US)

6

Name:

HUNT Terrence J.

Address:

United States (US)

7

Name:

SENEVIRATNE Ananda

Address:

United States (US)

8

Name:

MATHEWSON Don

Address:

United States (US)

Priority

1

Priority Number:

331816

Priority Date:

03/04/1989

Priority Country:

United States (US)

2

Priority Number:

121345 P

Priority Date:

10/12/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/19;

Publication

European Patent Bulletin

1

Issue number:

201708

Publication date:

22/02/2017

Description:

Opposition procedure started

2

Issue number:

202434

Publication date:

21/08/2024

Description:

Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages